Research Interests

My educational and academic background concerns different technical skills in molecular and cell biology. In particular I had the opportunity, during my research experience, to deepen my knowledge in drug−loaded nanosystem preparation, finally characterized in vitro and in vivo. I also acquired competences in MRI images acquisition and analysis, allowing to study the dynamic release of MRI contrast agents in tumour mouse model. The main aim of my PhD project is the preclinical development of a new MRI−guided therapeutic strategy to cure the ovarian cancer. The procedure is based on the systemic administration of theranostic nanocarriers followed by a tumour-directed application of combined sequence of nonthermal ultrasounds. The ultimate goals of my project are to improve the therapeutic performance of the drug, reducing the side effects and predicting the long−term outcome on an individual basis.